Communiqués Redcare Pharmacy NV

Actions

RDC

NL0012044747

Pharmacies

Marché Fermé - Xetra Autres places de cotation 17:37:43 15/06/2026			Varia. 5j.	Varia. 1 janv.
57,30 ^EUR	+17,37%		+16,94%	-11,98%

15/06	REDCARE PHARMACY : Jefferies favorable sur le dossier	ZD
15/06	Bourse de Francfort : l'accord avec l'Iran redonne de l'allant aux investisseurs	DP

Communiqués

15/06	Redcare Pharmacy accelerates growth, improves profitability and raises full-year 2026 guidance.	EQ
15/06	Redcare Pharmacy N.V.: Redcare Pharmacy reports stronger than expected Q2 2026 quarter-to-date trading and raises its full-year 2026 outlook.	EQ
08/05	Redcare Pharmacy : Transcript Earnings Release Call Q1 2026	PU
06/05	Redcare Pharmacy : Zwischenmitteilung Q1 2026	PU
06/05	Redcare Pharmacy : Interim Statement Q1 2026	PU
06/05	Redcare Pharmacy starts 2026 with a strong topline performance and a 58% increase of adj. EBITDA.	EQ
28/04	Change in Redcare Pharmacy’s Managing Board: Dirk Brüse to step down as CCO.	EQ
28/04	Change in Redcare Pharmacy’s Managing Board: Dirk Brüse to step down as CCO.	PU
28/04	Redcare Pharmacy: Dirk Brüse to step down as CCO.	EQ
22/04	Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.	EQ
16/04	Redcare Pharmacy : Supervisory Board Rotation Schedule Updated on 16/04/2026	PU
16/04	Redcare Pharmacy : Remuneration Policy Managing Board Updated on 16/04/2026	PU
16/04	Redcare Pharmacy : 2026 Stock Option Plan (Managing Board) Updated on 16/04/2026	PU
16/04	Redcare Pharmacy's Annual General Meeting 2026: All agenda items approved; Anja Hendel, Max Müller and Peter Schmid von Linstow new members of the Supervisory Board.	EQ
08/04	Redcare Pharmacy in Q1: non-Rx growth rebounds in Germany, while strong Rx growth continues.	EQ
11/03	Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo	PU
09/03	Redcare Pharmacy : Transcript Earnings Call FY 2025	PU
09/03	Redcare Pharmacy : Transkript Earnings Call FY 2025 (Englisch)	PU
09/03	Redcare Pharmacy : publishes inaugural Climate Transition Plan with new emissions targets	PU
05/03	Redcare Pharmacy : UBS Group AG - Redcare Pharmacy N.V. - Venlo	PU
04/03	Anja Hendel, Max Müller and Peter Schmid von Linstow to be nominated to the Supervisory Board of Redcare Pharmacy.	EQ
04/03	Redcare Pharmacy : Climate Transition Plan 2025 Updated on 04/03/2026	PU
04/03	Redcare Pharmacy : Geschäftsbericht 2025	PU
04/03	Redcare Pharmacy: Strong growth in 2025 surpassing EUR 1bn in Rx revenue; adj. EBITDA up 72% yoy.	EQ
03/03	Redcare Pharmacy N.V. announces guidance for 2026.	EQ